Private limited company · Tromsø
BIOTEC BETAGLUCANS AS
ActiveManufacture of other organic basic chemicals (20.140)
The life line 2010–2026
Operating revenue per year, with recorded events above. As a table
Operating revenue 2026: NOK 36.8m.
Sources: the Register of Company Accounts (company accounts), fetched 15 Nov 2026; the Brønnøysund Register Centre. Each event has the colour of the section it is in.
In brief
BIOTEC BETAGLUCANS AS is a private limited company in Tromsø, founded in 2010, in the industry manufacture of other organic basic chemicals. The chief executive is Michael Vinge, and the chair of the board is Francisco Pereira Da Conceicoa. In 2026 the company had NOK 36.8m in operating revenue and a net profit of NOK 5.6m.
Put together by Intelligo from the sections below; each figure stands with its source where it belongs.
Overview
§ 01 Latest changes
4 changes, latest 13 Nov 2026
- Number of employees 16 → 17
- Number of employees 15 → 16
- Fullmakt utdeling av utbytte
- Annual accounts filed 2025 → 2026
Source: the Brønnøysund Register Centre and Intelligo's own observations, fetched 15 Nov 2026 · All events →
Overview
§ 02 Worth knowing
2 points
- NoteChanged auditor 13 Apr 2026
- OKEquity ratio 49.6%, above the industry median
Assumed: derived by Intelligo by fixed rules, not a credit rating. How we calculate
Overview
§ 03 Key figures
Revenue NOK 36.8m in 2026
Revenue
NOK 36.8m
−19.8% from 2025
20242026
Operating profit
NOK 6.3m
−15.9% from 2025
20242026
Net profit
NOK 5.6m
−27.4% from 2025
20242026
Equity
NOK 23.3m
+31.6% from 2025
20242026
Source: the Register of Company Accounts, read 15 Nov 2026 · The full accounts →
Finances
§ 04 Where the money comes from and goes
Financial year 2026
Of every krone of operating revenue in 2026:
- Wages and social costs 32%
- Depreciation 3%
- Other operating costs 30%
- Not specified in the source 18%
- Left as operating result 17%
Of the net profit for 2026, NOK 5.6m stayed in the company. The rest, NOK 2, is an assumed dividend.
The assumed dividend is derived by Intelligo from the change in equity, not stated by the source. Source: the Register of Company Accounts via areg.no, read 15 Nov 2026
Finances
§ 05 Financial health
Equity ratio 49.6%
- BIOTEC BETAGLUCANS AS, 2026
- Industry median, assumed: NOK 103.6m · 5.9% · 42.6% · +6.9%
Equity NOK 23.3m50% of the assets (NOK 46.9m)
Source: the Register of Company Accounts, read 15 Nov 2026. The median is derived by Intelligo from 32 companies in industry section C, not stated by the source.
Finances
§ 06 Accounts
16 years, latest 2026
| NOK 1,000 | 2024–26 | 2026 | 2025 | 2024 |
|---|---|---|---|---|
| Operating revenue | 36,768 | 45,861 | 32,462 | |
| Operating profit | 6,254 | 7,434 | 3,613 | |
| Profit before tax | 5,590 | 7,696 | 3,417 | |
| Net profit | 5,590 | 7,696 | 3,417 | |
| Total assets | 46,876 | 34,044 | 33,234 | |
| Equity | 23,271 | 17,681 | 13,986 | |
| Liabilities | 23,604 | 16,363 | 19,248 |
Source: the Register of Company Accounts, read 15 Nov 2026 · All 16 years →
Management and ownership
§ 07 Officers
8 officers now
- Michael VingeChief executive since 2021
- AGENDA ØKONOMI ASAccountant
- Francisco Pereira Da ConceicoaChair of the board since 2022
- TELL NORGE ASAuditor since 2026
- Michael VingeBoard member since 2021
- Rolf Einar EngstadBoard member since 2011
Source: the Brønnøysund Register Centre, read 23 Oct 2026 · All 8 roles, former ones too →
Management and ownership
§ 08 Signature, procuration and authorisations
To styremedlemmer i fellesskap.
May sign for the company:
To styremedlemmer i fellesskap.
Procuration: none registered.
The signature is word for word from the register. Source: the Register of Business Enterprises, read 25 Aug 2026
Management and ownership
§ 09 Owners
None registered
No owners registered.The Tax Administration's shareholder register covers limited companies and has no owners for this business. Checked 15 Nov 2026.
Management and ownership
§ 10 Group
None registered
Not a group.No subsidiaries in the shareholder register, and no group accounts. Checked 15 Nov 2026.
Management and ownership
§ 11 Portfolio
None registered
No holdings registered.The shareholder register has no shares held by the company. Checked 15 Nov 2026.
Management and ownership
§ 12 Network
2 connections
- Person
- Company
2 people link BIOTEC BETAGLUCANS AS to 2 other companies: Michael Omvik-Grotkjær 1 and Rolf Einar Engstad 1.
Source: the Brønnøysund Register Centre, read 23 Oct 2026 · Explore the network →
Events and registers
§ 13 Events
49 since 2015
Events per year
20152026
Since 2015: 62 announcements and 3 register changes. Most happened in 2021 and 2026.
Source: the announcements of the Brønnøysund Register Centre, the Tax Administration's Register of Shareholders, Doffin, TED and NAV, read 2 Nov 2026. Register changes are Intelligo's own observations. · All 49 events →
Events and registers
§ 14 Notices
62, latest 22 Jul 2026
- Utdeling av utbytte - fullmakt
- Godkjente årsregnskap
- Revisor
Source: The Brønnøysund Register Centre's announcements ↗, read 2 Nov 2026 · All 62 →
Events and registers
§ 15 Charges
Not fetched yet
Events and registers
§ 16 Other registers
Found in 3 of 7
- The Central Coordinating RegisterRegistered 5 Jan 2011
- VATRegistered
- The Register of Business EnterprisesRegistered 5 Jan 2011
- The Cleaning RegisterNot registered
- The Register of Staffing AgenciesNot registered
- Smiley scheme, the Norwegian Food Safety AuthorityNot registered
- The Financial Supervisory Authority's licence registerNot registered
Purpose: Forskning, utvikling, produksjon, markedsføring og salg av aktive immunmodulerende ingredienser til bruk i farmasøytiske spesialpreparater, medisinsk-teknisk utstyr, helsekost, kosmetikk, «functional food» og fôr-produkter. Selskapet skal fremme utvikling av produkter og teknologisk viten innenfor sine virksomhetsområder, og skal kunne gjøre investeringer i andre selskaper innenfor disse områdene.
Source: the Brønnøysund Register Centre, the Labour Inspection Authority, the Food Safety Authority and the Financial Supervisory Authority, each on its own, fetched 15 Nov 2026
Market
§ 17 Tenders
None registered
No tenders recorded.No public tenders won, lost or announced, in Doffin or TED. Checked 15 Nov 2026.
Market
§ 18 Vacancies
None registered
No vacancies.No open ads at NAV. Checked 15 Nov 2026.
Market
§ 19 Competitors
Industry code 20.140
The companies most like it:
Compare themThe selection is Intelligo's, not stated by the source: companies met in tenders and winners of tenders of the same kind, otherwise the same industry code, nearest in place and size. Source: the Brønnøysund Register Centre, Doffin and TED, fetched 15 Nov 2026 · All competitors → · Largest in the industry →
Last
§ 20 Questions and answers
6 questions
- Who is the chief executive of BIOTEC BETAGLUCANS AS?
Michael Vinge, since 2021. § 07 - What was the revenue in 2026?
NOK 36.8m in the company. § 06 - Who can sign for BIOTEC BETAGLUCANS AS?
To styremedlemmer i fellesskap. § 08 - Who is the auditor?
TELL NORGE AS, from 13 Apr 2026. § 07 - Where is BIOTEC BETAGLUCANS AS based?
Stakkevollvegen 65, 9010 Tromsø. - When was BIOTEC BETAGLUCANS AS founded?
26 Nov 2010, registered in the Register of Business Enterprises 5 Jan 2011. § 16
The answers come from the sections linked to, with their sources.